Neuralstem CEO Blog

RSS
  • “O brave new world...”

    (Miranda, The Tempest Act 5, Scene 1)

Posted: May 22nd, 2013

On Friday last week, Dr. Eva Feldman spoke at a conference in Europe, and presented data from our Phase I ALS trial; data on all 15 patients (18 surgeries as 3 patients came back for a second transplantation) from the beginning of the trial nearly 3 years ago through mid February of 2013, 6 months after the last surgery as required by the FDA.

Read more...

  • "The best thing about the future is that it comes one day at a time"

    - Abraham Lincoln

Posted: March 19th, 2013

There is often a disconnect between the urgency one feels in working to find cures for fatal and incurable diseases, and the realistic time frames required for even the best cutting edge science to move from bench to bedside. Stem cell science presents us with such disconnects. It is clear to all involved that yet more urgency and more speed are needed. Yet by traditional standards we are still early in the clinical process, even as we put all of our resources into attempts to accelerate the process. There is however, an area of stem cell science where therapeutic intervention is possible today. In a bit of a departure for this space, I would like to draw your attention to the battle against Leukemia and various blood cancers through the fight for survival of two inspirational patients.

Read more...

  • "You never want a serious crisis to go to waste"

    - Rahm Emanuel (attribution)

Posted: February 27th, 2013

As callous and cold hearted as this sounds, it is a political truism. There are some systems, some bureaucracies that are so gridlocked, or so moribund that only the urgency that comes from dealing with a crisis can create enough momentum to make progress. The FDA held a hearing on Monday to allow the ALS community to voice their opinions on how to proceed with ALS research. While it is unclear exactly what precipitated the calling of this hearing, the failure of the Phase III Biogen “dex” trial to treat ALS patients has perhaps, finally created a “crisis” mode at the FDA. The audience was able to assure the FDA that they are already in crisis mode.

Read more...

  • “There's a kind of a sort of : cost
    There's a couple of things get: lost”


    (Wicked)

Posted February 7, 2013

The FDA has called a public hearing late in February to solicit ideas and opinions on how they should think about, and evaluate clinical trials to treat ALS.  The Agency has come under criticism over the past year for not being “supportive” enough of novel treatments for incurable diseases (like ALS) and innovation in general.  The FDA has responded basically by stating that supporting innovation is not their mission and that their job is to make sure medicines are safe and actually work.  The FDA is (rightly) considered the “gold standard” throughout the world.  This reputation as the “toughest” regulatory agency to deal with is a reputation they fight to maintain, and they believe that through such diligence they can best protect the American public.

Read more...

  • “The accident was a horrible thing - but that horrible thing made Chris, at the end of his life, Superman. It's a happy irony if there is such a thing. I'm proud to have known him.”

    Morgan Freeman

Posted January 15, 2013

Yesterday, Neuralstem announced that the FDA approved our spinal cord injury trial (SCI). It’s hard not to think of Chris Reeve at a time like this. I actually met him once, at a dinner party in London in 1979. He was filming the second Superman movie, a remarkably quiet and unassuming young man given his enormous physical gifts and burgeoning fame. That he is synonymous now with the effort to cure spinal cord injury is a tribute to the efforts he put into his foundation’s work from the time of his accident until his death.

Read more...

Privacy and Terms ©Neuralstem, Inc. 2013